Menu
Back to User profile » Dr Nathan Herrmann
Papers published by Dr Nathan Herrmann:
The value of screening for cognition, depression, and frailty in patients referred for TAVI
Khan MM, Lanctôt KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, Gandell D, Brenkel MC, Hazan EL, Docteur NG, Herrmann N
Clinical Interventions in Aging 2019, 14:841-848
Published Date: 8 May 2019
Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL
Neuropsychiatric Disease and Treatment 2016, 12:2913-2920
Published Date: 10 November 2016
A meta-analysis of lipid peroxidation markers in major depression
Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL
Neuropsychiatric Disease and Treatment 2015, 11:2479-2491
Published Date: 29 September 2015
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SAL, Lanctôt KL
Neuropsychiatric Disease and Treatment 2015, 11:2309-2314
Published Date: 4 September 2015
Kynurenine and depressive symptoms in a poststroke population
Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL
Neuropsychiatric Disease and Treatment 2014, 10:1827-1835
Published Date: 22 September 2014